Filer Snapshot

ZOGENIX, INC.

CIK 0001375151. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Company

Total filings

16

Latest filing

09 Mar 2022

Industry

Pharmaceutical Preparations

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: SEC filing timeline only. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Largest parsed holding

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Forms 3/4/5

4 filed on 09 Mar 2022 for CIK 0001375151.

View Source Filing
Filer identity 2 facts
Business address
5959 Horton Street, Suite 500, Emeryville, CA, 94608
SEC record 2 facts
State of incorporation
DE
Fiscal year-end
31 December

Filer intelligence

What SEC filings say about ZOGENIX, INC.

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

No XML rows yet
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Forms 3/4/5 No rows yet

Officer, director, and 10% owner holdings or transactions.

No parsed ownership summary yet

We still show the SEC filing timeline below. The intelligence summary will populate when parsed 13F, 13D/G, or Forms 3/4/5 data exists for this CIK.

SEC filing record

CIK 0001375151 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
16
First seen
28 May 2021
Latest filing
09 Mar 2022
Entity
Company

Industry context: Pharmaceutical Preparations.

Latest Filings

Showing the latest 12 of 16 SEC filings for ZOGENIX, INC..

4

4 filing

Filing date
09 Mar 2022
Reporting date
07 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Mar 2022
Reporting date
07 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Mar 2022
Reporting date
07 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Mar 2022
Reporting date
07 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Mar 2022
Reporting date
07 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Mar 2022
Reporting date
07 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Mar 2022
Reporting date
07 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 Nov 2021
Reporting date
29 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Aug 2021
Reporting date
09 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Aug 2021
Reporting date
09 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Jul 2021
Reporting date
02 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Jun 2021
Reporting date
01 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .